Louisa von Baumgarten

4.6k total citations · 1 hit paper
80 papers, 2.5k citations indexed

About

Louisa von Baumgarten is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Louisa von Baumgarten has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 27 papers in Pulmonary and Respiratory Medicine and 26 papers in Neurology. Recurrent topics in Louisa von Baumgarten's work include Glioma Diagnosis and Treatment (34 papers), Brain Metastases and Treatment (18 papers) and CNS Lymphoma Diagnosis and Treatment (14 papers). Louisa von Baumgarten is often cited by papers focused on Glioma Diagnosis and Treatment (34 papers), Brain Metastases and Treatment (18 papers) and CNS Lymphoma Diagnosis and Treatment (14 papers). Louisa von Baumgarten collaborates with scholars based in Germany, United States and Netherlands. Louisa von Baumgarten's co-authors include Frank Winkler, Yvonne Kienast, Jochen Herms, Martin Fuhrmann, Roland Goldbrunner, Wolfgang E. F. Klinkert, Andreas Straube, Steffen Burgold, Wieland H. Sommer and Kolja M. Thierfelder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Louisa von Baumgarten

76 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-time imaging reveals the single steps of brain metastasis formation

2009 825 citations Yvonne Kienast, Louisa von Baumgarten et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Louisa von Baumgarten Germany	24	861	719	665	637	549	80	2.5k
Joerg‐Christian Tonn Germany	29	620 0.7×	687 1.0×	1.7k 2.5×	729 1.1×	526 1.0×	111	3.6k
Arnold B. Etame United States	28	874 1.0×	876 1.2×	606 0.9×	531 0.8×	157 0.3×	92	2.4k
Nils Ole Schmidt Germany	28	689 0.8×	417 0.6×	1.1k 1.6×	1.6k 2.5×	713 1.3×	134	3.7k
Sherise D. Ferguson United States	26	441 0.5×	513 0.7×	653 1.0×	519 0.8×	378 0.7×	94	2.0k
Gerda Ricken Austria	24	858 1.0×	561 0.8×	585 0.9×	514 0.8×	417 0.8×	55	2.1k
David Meyronet France	27	338 0.4×	395 0.5×	1.0k 1.5×	878 1.4×	609 1.1×	115	2.6k
Julian K. Wu United States	30	583 0.7×	561 0.8×	895 1.3×	942 1.5×	1.4k 2.5×	89	3.7k
Alessandro Della Puppa Italy	32	543 0.6×	516 0.7×	1.5k 2.2×	938 1.5×	451 0.8×	172	3.2k
Takanori Ohnishi Japan	33	480 0.6×	325 0.5×	715 1.1×	1.1k 1.8×	775 1.4×	146	3.5k
Christopher M. Jackson United States	24	1.2k 1.4×	431 0.6×	871 1.3×	514 0.8×	363 0.7×	103	2.7k

Countries citing papers authored by Louisa von Baumgarten

Since Specialization

Citations

This map shows the geographic impact of Louisa von Baumgarten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louisa von Baumgarten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louisa von Baumgarten more than expected).

Fields of papers citing papers by Louisa von Baumgarten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Louisa von Baumgarten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louisa von Baumgarten. The network helps show where Louisa von Baumgarten may publish in the future.

Co-authorship network of co-authors of Louisa von Baumgarten

This figure shows the co-authorship network connecting the top 25 collaborators of Louisa von Baumgarten. A scholar is included among the top collaborators of Louisa von Baumgarten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Louisa von Baumgarten. Louisa von Baumgarten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Müller, Katharina, Steffen Tiedt, Samuel Knauß, et al.. (2025). Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors. International Journal of Cancer. 156(10). 1961–1971. 1 indexed citations

Trumm, Christoph, Patrick N. Harter, Louisa von Baumgarten, et al.. (2024). Determinants of long-term survival in patients with IDH-mutant gliomas. Journal of Neuro-Oncology. 170(3). 655–664. 2 indexed citations

Nayak, Lakshmi, Chetan Bettegowda, Florian Scherer, et al.. (2024). Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. Neuro-Oncology. 26(6). 993–1011. 11 indexed citations

Xu, Tao, Alexander Beck, Katharina Müller, et al.. (2024). PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis. Cancer Immunology Immunotherapy. 73(12). 255–255. 1 indexed citations

Baumgarten, Louisa von, et al.. (2023). Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy. Cancer Immunology Immunotherapy. 72(9). 3111–3124. 1 indexed citations

Baumgarten, Louisa von, Hans J. Stauss, & Jan D. Lünemann. (2023). Synthetic Cell-Based Immunotherapies for Neurologic Diseases. Neurology Neuroimmunology & Neuroinflammation. 10(5). 8 indexed citations

Müller, Katharina, Annamaria Biczok, Christian Schichor, Louisa von Baumgarten, & Nathalie L. Albert. (2023). The value of [18F]FET PET and somatostatin receptor imaging for differentiating pseudoprogression in residual meningioma. European Journal of Nuclear Medicine and Molecular Imaging. 51(4). 1194–1196. 3 indexed citations

Kaulen, Leon D., Felix Hinz, Octavian Henegariu, et al.. (2023). Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas. Acta Neuropathologica. 146(3). 499–514. 9 indexed citations

Albert, Nathalie L., Adrien Holzgreve, Marcus Unterrainer, et al.. (2023). Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas. Zeitschrift für Medizinische Physik. 33(1). 91–102. 8 indexed citations

10.

Quach, Stefanie, Adrien Holzgreve, Louisa von Baumgarten, et al.. (2022). Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4282–4283. 1 indexed citations

11.

Karschnia, Philipp, Émilie Le Rhun, Michael A. Vogelbaum, et al.. (2021). The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy. European Journal of Cancer. 156. 93–108. 16 indexed citations

12.

Karschnia, Philipp, Nico Teske, Mario M. Dorostkar, et al.. (2020). Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II. Scientific Reports. 10(1). 19758–19758. 9 indexed citations

13.

Mulazzani, Matthias, Simon P. Fräßle, Hellen Ishikawa‐Ankerhold, et al.. (2019). Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice. Proceedings of the National Academy of Sciences. 116(48). 24275–24284. 73 indexed citations

14.

Mulazzani, Matthias, Sabine Borchard, Barbara Angele, et al.. (2019). APRIL and BAFF: novel biomarkers for central nervous system lymphoma. Journal of Hematology & Oncology. 12(1). 102–102. 26 indexed citations

15.

Baumgarten, Louisa von, Gerald Illerhaus, Agnieszka Korfel, et al.. (2018). The Diagnosis and Treatment of Primary CNS Lymphoma. Deutsches Ärzteblatt international. 115(25). 419–426. 52 indexed citations

16.

Ilhan‐Mutlu, Aysegül, Matthias Osswald, Yunxiang Liao, et al.. (2016). Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma. Molecular Cancer Therapeutics. 15(4). 702–710. 86 indexed citations

17.

Baumgarten, Louisa von, Yvonne Kienast, Stefan Grau, et al.. (2011). Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells. Clinical Cancer Research. 17(19). 6192–6205. 137 indexed citations

18.

Grau, Stefan, et al.. (2011). Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells. Journal of Neuro-Oncology. 104(1). 103–112. 29 indexed citations

19.

Egea, Virginia, Louisa von Baumgarten, Benedikt Berninger, et al.. (2010). TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma. Cell Death and Differentiation. 18(5). 853–863. 70 indexed citations

20.

Plesnila, Nikolaus, Louisa von Baumgarten, Doortje C. Engel, et al.. (2007). Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-κB transcriptional activity. Cell Death and Differentiation. 14(8). 1529–1541. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact